Harte-Hanks (HHS) said Monday that it acquired an exclusive license to ADS Data Direct's medical ailment database, with limited client exceptions.
Financial terms of the transaction were not disclosed.
ADS's data asset gives access to triple opt-in consumers who have self-identified as living with specific health conditions across more than 200 ailment categories.
Harte-Hanks' shares were up 5.7% in recent trading.
Price: 4.81, Change: +0.26, Percent Change: +5.67
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.